Package 16571-833-16

Brand: pryidostigmine bromide

Generic: pyridostigmine bromide
NDC Package

Package Facts

Identity

Package NDC 16571-833-16
Digits Only 1657183316
Product NDC 16571-833
Product ID 16571-833_b46177b2-68dc-4958-a4ec-d4bd6d887456
Description

473 mL in 1 BOTTLE, PLASTIC (16571-833-16)

Marketing

Marketing Status
Marketed Since 2022-09-15
Brand pryidostigmine bromide
Generic pyridostigmine bromide
Sample Package No

Linked Drug Pages (1)

Pryidostigmine Bromide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b46177b2-68dc-4958-a4ec-d4bd6d887456", "openfda": {"upc": ["0316571833160"], "unii": ["KVI301NA53"], "rxcui": ["903843"], "spl_set_id": ["beda905e-005a-439d-ac74-92db4e269780"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE, PLASTIC (16571-833-16)", "package_ndc": "16571-833-16", "marketing_start_date": "20220915"}], "brand_name": "Pryidostigmine Bromide", "product_id": "16571-833_b46177b2-68dc-4958-a4ec-d4bd6d887456", "dosage_form": "SOLUTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "16571-833", "generic_name": "Pyridostigmine Bromide", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pryidostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "60 mg/5mL"}], "application_number": "ANDA208797", "marketing_category": "ANDA", "marketing_start_date": "20220915", "listing_expiration_date": "20261231"}